You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
恆指跌幅擴至逾280點 美團、小米、藥明生物及中升挫逾4%至5%
恆指四連跌累挫512點或3%後,今早在金融股支撐高開46點或近0.3%報16,581,早段反覆高見16,592無以為繼,最低見16,235,現報16,255,跌284點或1.7%,總成交額319億元。此外,恆生科指今早下滑3.1%報3,480。 藍籌股普遍下跌,尤其是美團(03690.HK)、小米(01810.HK)及京東(09618.HK)齊挫逾4%,分別報74.4元、14.32元及100.7元。阿里(09988.HK)及網易(09999.HK)續跌2.5%-3.5%,分別報69.75元及140.7元;騰訊(00700.HK)高開近0.8%報294.4元欠承接,掉頭續跌2%報286.4元。 內需股以蒙牛(02319.HK)、吉利(00175.HK)、比亞迪(01211.HK)、海底撈(06862.HK)、李寧(02331.HK)、潤啤(00291.HK)及中升(00881.HK)跌逾2%-5.5%。 華潤萬象(01209.HK)跌逾4%,股價曾再觸及52周低位25.05元。此外,醫藥股以藥明生物(02269.HK)沽壓最大,股價創逾三年低,現報26.3元即市低位,挫4.5%。 然而,匯控(00005.HK)高見63.4元,現報62.75元,續升0.5%。中海油(00883.HK)股價曾高見13.9元。神華(01088.HK)回升1%報28.4元。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account